Clinical Trial 42551

Gilbert, AZ 85295


Study Summary:

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel Group Study To Evaluate Safety, Tolerability And Pharmacodynamics of Pf-06835919 Administered Daily For 16 Weeks In Adults With Non-Alcoholic Fatty Liver Disease And Type 2 Diabetes Mellitus On Metformin


Qualified Participants Must:

• Have Type 2 Diabetes
• Age 18-70 years old
• Metformin monotherapy


Qualified Participants May Receive:

May receive compensation for Travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.